BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14522109)

  • 1. AIDS-associated Cryptococcus infection before and after the highly active antiretroviral therapy era: emerging management problems.
    Manfredi R; Calza L; Chiodo F
    Int J Antimicrob Agents; 2003 Oct; 22(4):449-52. PubMed ID: 14522109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microbiological aspects of the cryptococcosis in the post-HAART era].
    Mazuelos EM; García AI
    Enferm Infecc Microbiol Clin; 2010 Jan; 28 Suppl 1():40-5. PubMed ID: 20172422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptococcosis: a review of the Brazilian experience for the disease.
    Pappalardo MC; Melhem MS
    Rev Inst Med Trop Sao Paulo; 2003; 45(6):299-305. PubMed ID: 14762626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy.
    Antinori S; Ridolfo A; Fasan M; Magni C; Galimberti L; Milazzo L; Sollima S; Adorni F; Giuliani G; Galli M; Corbellino M; Parravicini C
    HIV Med; 2009 Jan; 10(1):6-11. PubMed ID: 19125961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing face of AIDS-related opportunism: cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review.
    Manfredi R; Pieri F; Pileri SA; Chiodo F
    Mycopathologia; 1999 Nov; 148(2):73-8. PubMed ID: 11189746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on Cryptococcus among HIV-infected patients.
    Warkentien T; Crum-Cianflone NF
    Int J STD AIDS; 2010 Oct; 21(10):679-84. PubMed ID: 21139145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras.
    Dromer F; Mathoulin-Pélissier S; Fontanet A; Ronin O; Dupont B; Lortholary O;
    AIDS; 2004 Feb; 18(3):555-62. PubMed ID: 15090810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Candida albicans and Cryptococcus neoformans fungaemia in an AIDS presenter: a unique disease association in the highly active antiretroviral therapy (HAART) era.
    Manfredi R; Calza L; Chiodo F
    J Med Microbiol; 2002 Dec; 51(12):1135-1137. PubMed ID: 12466414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
    Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N
    Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV/AIDS-Associated Cryptococcosis in Portugal Spanning the Pre- to Post-HAART Era: A Retrospective Assessment at the Genotypic Level Based on URA5-RFLP.
    Maduro AP; Gonçalves L; Inácio J; Faria NC; Martins ML; Teles FR
    Curr Microbiol; 2015 Oct; 71(4):449-57. PubMed ID: 26169111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS-associated central nervous system cryptococcosis: a Brazilian case study.
    Pappalardo MC; Paschoal RC; Melhem MS
    AIDS; 2007 Sep; 21(14):1971-2. PubMed ID: 17721106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy.
    van Elden LJ; Walenkamp AM; Lipovsky MM; Reiss P; Meis JF; de Marie S; Dankert J; Hoepelman AI
    AIDS; 2000 Dec; 14(17):2787-8. PubMed ID: 11125898
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cryptococcus neoformans infections in patients infected and not infected with HIV].
    Miró Meda JM; Mallolas Masferrer J; Moreno-Camacho A; Marco Reverter F; García Alcaide F
    Rev Clin Esp; 1997 Apr; 197 Suppl 1():49-59. PubMed ID: 9297207
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV-associated tuberculosis and cryptococcosis in resource-limited settings.
    Lalloo UG; Amod FC
    Curr HIV/AIDS Rep; 2005 Aug; 2(3):116-21. PubMed ID: 16091257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcal disease and HIV infection.
    Waters L; Nelson M
    Expert Opin Pharmacother; 2005 Dec; 6(15):2633-44. PubMed ID: 16316302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous occurrence of 2 HIV-related immunereconstitution diseases after initiation of highly active antiretroviral therapy.
    Legendre U; Battegay M; Nuttli I; Dalquen P; Nuesch R
    Scand J Infect Dis; 2001; 33(5):388-9. PubMed ID: 11440230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cryptococcal meningoencephalitis. Epidemiology and mortality risk factors in pre- and post-HAART era].
    Cabello Úbeda A; Fortes Alen J; Gadea I; Mahillo I; Górgolas M; Fernández Guerrero ML
    Med Clin (Barc); 2016 May; 146(9):397-401. PubMed ID: 26971986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cryptococcosis in AIDS patients: case study from 1996 to 2006 in Paroissien Hospital].
    Mónaco LS; Tamayo Antabak N
    Rev Argent Microbiol; 2008; 40(4):218-21. PubMed ID: 19213244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy.
    Jenny-Avital ER; Abadi M
    Clin Infect Dis; 2002 Dec; 35(12):e128-33. PubMed ID: 12471589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.